Anika Therapeutics Inc.

NASDAQ:ANIK   2:03:07 PM EDT
29.48
-0.86 (-2.84%)
Earnings Announcements

Anika Therapeutics Inc Reports Quarterly Loss Per Share Of $0.29

Published: 11/08/2022 23:06 GMT
Anika Therapeutics Inc. (ANIK) - Anika Reports Third Quarter Fiscal 2022 Financial Results.
Anika Therapeutics Inc - Revenue in Q3 of 2022 Was $40.3 Million, Up 2%.
Anika Therapeutics Inc - Quarter Loss per Share of $0.29.
Anika Therapeutics Inc - Qtrly Adjusted Net Loss of $0.05 per Share.
Anika Therapeutics Inc - Quarter Ending Cash Was $87.8 Million.
Revenue is expected to be $37.71 Million
Adjusted EPS is expected to be -$0.24

Next Quarter Revenue Guidance is expected to be $38.95 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.